|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization of property, equipment and internal-use software | |||||
| Amortization of intangible assets | |||||
| Provision for uncollectible overdrawn accounts from purchase transactions | |||||
| Provision for loan losses | |||||
| Stock-based compensation | |||||
| Losses in equity method investments | |||||
| Realized loss on available-for-sale investment securities | |||||
| Amortization of premium and discount on available-for-sale investment securities | |||||
| Impairment of long-lived assets | |||||
| Deferred income tax expense (benefit) | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Deferred expenses | |||||
| Accounts payable and other accrued liabilities | |||||
| Deferred revenue | |||||
| Income tax receivable/payable | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of available-for-sale investment securities | |||||
| Proceeds from maturities of available-for-sale securities | |||||
| Proceeds from sales and calls of available-for-sale securities | |||||
| Payments for property, equipment and internal-use software | |||||
| Net changes in loans | |||||
| Investment in TailFin Labs, LLC | |||||
| Purchase of other investments, net | |||||
| Other investing activities | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities | |||||
| Borrowings on notes payable | |||||
| Borrowings on revolving line of credit | |||||
| Repayments on revolving line of credit | |||||
| Proceeds from exercise of options and ESPP purchases | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net changes in deposits | |||||
| Net changes in settlement assets and obligations to customers | |||||
| Contingent consideration payments | |||||
| Repurchase of Class A common stock | |||||
| Deferred financing costs | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in unrestricted cash, cash equivalents and restricted cash | |||||
| Unrestricted cash, cash equivalents and restricted cash, beginning of period | |||||
| Unrestricted cash, cash equivalents and restricted cash, end of period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Unrestricted cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...